Q2 2023 Holdings
Filed 2023-08-09 | 8 holdings | $84.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $28.0M | 2,646,657 | 33.2% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $28.0M | 498,558 | 33.2% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $8.1M | 5,068,233 | 9.6% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $6.9M | 3,561,150 | 8.2% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $6.0M | 543,753 | 7.1% |
| Passage Bio, Inc. | Common Stock | 702712100 | $4.7M | 4,959,769 | 5.5% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.3M | 2,320,381 | 2.7% |
| Minerva Surgical Inc. | Common Stock | 60343F106 | $428.8K | 1,673,700 | 0.5% |